Successful weight reduction improves left ventricular diastolic function and physical performance in severe obesity

International Heart Journal

Volumn 56, Issue 2, 2015, Pages 196-202

  Fenk, Sabine ^a   Fischer, Marcus ^a   Strack, Christina ^a   Schmitz, Gerd ^a   Loew, Thomas ^a   Lahmann, Claas ^b   Baessler, Andrea ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adiposity; Diastolic dysfunction; Metabolic syndrome; Weight loss

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CALORIC RESTRICTION; CARDIOVASCULAR RISK; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL FEATURE; DIASTOLIC DYSFUNCTION; DIET; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; WEIGHT REDUCTION; COMPLICATION; LONGITUDINAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; CALORIC RESTRICTION; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; VENTRICULAR DYSFUNCTION, LEFT; WEIGHT LOSS;

EID: 84929942520     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.14-261     Document Type: Article

References (43)

1. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CWJr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-105.
2. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195-200.
3. Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105-20.
4. Romero-Corral A, Montori VM, Somers V., et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006; 368: 666-78. (Review).
5. Paulus WJ, Tschöpe C, Sanderson JE, et al. How to diagnose di-astolic heart failure: a consensus statement on the diagnosis of Heart Failure and Echocardiography Associations of the European heart failure with normal left ventricular ejection fraction by the Society of Cardiology. Eur Heart J 2007; 28: 2539-50.
6. Bibbins-Domingo K, Pletcher MJ, Lin F, et al. Racial differences in incident heart failure among young adults. N Engl J Med 2009; 360: 1179-90.
7. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305-13.
8. Fischer M, Baessler A, Hense HW, et al. Prevalence of left ven-tricular diastolic dysfunction in the community: Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003; 24: 320-8.
9. Lee DS, Gona P, Vasan RS, et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation 2009; 119: 3070-7.
10. Hainer V, Hlavatá K, Gojová M, et al. Hormonal and psychobe-havioral predictors of weight loss in response to a short-term weight reduction program in obese women. Physiol Res 2008; 57: S17-27.
11. Murer SB, Knöpfli BH, Aeberli I, et al. Baseline leptin and leptin reduction predict improvements in metabolic variables and long-term fat loss in obese children and adolescents: a prospective study of an inpatient weight-loss program. Am J Clin Nutr 2011; 93: 695-702.
12. Baessler A, Strack C, Rousseva E, et al. Growth-differentiation factor-15 improves reclassification for the diagnosis of heart fail-ure with normal ejection fraction in morbid obesity. Eur J Heart Fail 2012; 14: 1240-8.
13. Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a re-view of research and clinical applications. J Am Soc Echocardiogr 2009; 22: 1311-9. (Review).
14. Lin LI. A concordance correlation coefficient to evaluate repro-ducibility. Biometrics 1989; 45: 255-68.
15. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocar-diography. Eur J Echocardiogr 2009; 10: 165-93. (Review).
16. Zientek LR, Thompson B. Commonality analysis: partitioning variance to facilitate better understanding of data. J Early Interv 2006; 28: 299-307.
17. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Red-field MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-9.
18. Aljaroudi W, Alraies MC, Halley C, et al. Impact of progression of diastolic dysfunction on mortality in patients with normal ejec-tion fraction. Circulation 2012; 125: 782-8.
19. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure--abnor-malities in active relaxation and passive stiffness of the left ventri-cle. N Engl J Med 2004; 350: 1953-9.
20. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995; 26: 1565-74. (Review).
21. Wong CY, O’Moore-Sullivan T, Leano R, Byrne N, Beller E, Mar-wick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004; 110: 3081-7.
22. Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMur-ray JJ. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew–Paisley study). Eur Heart J 2006; 27: 96-106.
23. Rider OJ, Francis JM, Ali MK, et al. Beneficial cardiovascular ef-fects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol 2009; 54: 718-26.
24. Peterson LR, Waggoner AD, Schechtman KB, et al. Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler im-aging. J Am Coll Cardiol 2004; 43: 1399-404.
25. Otto ME, Belohlavek M, Khandheria B, Gilman G, Svatikova A, Somers V. Comparison of right and left ventricular function in obese and nonobese men. Am J Cardiol 2004; 93: 1569-72.
26. Cavalcante JL, Tamarappoo BK, Hachamovitch R, et al. Associa-tion of epicardial fat, hypertension, subclinical coronary artery disease, and metabolic syndrome with left ventricular diastolic dysfunction. Am J Cardiol 2012; 110: 1793-8.
27. Unick JL, Beavers D, Bond DS, et al. The Long-term effective-ness of a lifestyle intervention in severely obese individuals. Am J Med 2013; 126: 236-42.
28. Rubin RR, Peyrot M, Gaussoin SA, et al. Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes. Diabe-tes Care 2013; 36: 1088-94.
29. Jordan J, Yumuk V, Schlaich M, et al. Joint statement of the Euro-pean Association for the Study of Obesity and the European Soci-ety of Hypertension: obesity and difficult to treat arterial hyperten-sion. J Hypertens 2012; 30: 1047-55.
30. Goodpaster BH, Delany JP, Otto AD, et al. Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA 2010; 304: 1795-802.
31. Chockalingam A, Linden MA, Del Rosario M, Govindarajan G, Dellsperger KC, Thomas TR. Exercise and weight loss improve exercise capacity independent of cardiac function in metabolic syndrome. Angiology 2010; 61: 192-7.
32. Wong C, Marwick TH. Obesity cardiomyopathy: pathogenesis and pathophysiology. Nat Clin Pract Cardiovasc Med 2007; 4: 436-43. (Review).
33. Eckel RH, York DA, Rössner S, et al. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: executive summary. Circulation 2004; 110: 2968-75.
34. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005; 2: 536-43. (Review).
35. Lamounier-Zepter V, Look C, Alvarez J, et al. Adipocyte fatty ac-id-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 2009; 105: 326-34.
36. Alpert MA, Lambert CR, Terry BE, et al. Effect of weight loss on left ventricular diastolic filling in morbid obesity. Am J Cardiol 1995; 76: 1198-201.
37. Kanoupakis E, Michaloudis D, Fraidakis O, Parthenakis F, Vardas P, Melissas J. Left ventricular function and cardiopulmonary per-formance following surgical treatment of morbid obesity. Obes Surg 2001; 11: 552-8.
38. Karason K, Wallentin I, Larsson B, Sjöström L. Effects of obesity and weight loss on left ventricular mass and relative wall thick-ness: survey and intervention study. BMJ 1997; 315: 912-6.
39. Willens HJ, Chakko SC, Byers P, et al. Effects of weight loss after gastric bypass on right and left ventricular function assessed by tissue Doppler imaging. Am J Cardiol 2005; 95: 1521-4.
40. Kirschenbaum DS, Gierut K. Treatment of childhood and adoles-cent obesity: an integrative review of recent recommendations from five expert groups. J Consult Clin Psychol 2013; 81: 347-60. (Review).
41. 2). Am J Cardiol 2006; 98: 1593-8.
42. Skilton MR, Sieveking DP, Harmer JA, et al. The effects of obesi-ty and non-pharmacological weight loss on vascular and ventricu-lar function and structure. Diabetes Obes Metab 2008; 10: 874-84.
43. Rider OJ, Francis JM, Tyler D, Byrne J, Clarke K, Neubauer S. Effects of weight loss on myocardial energetics and diastolic func-tion in obesity. Int J Cardiovasc Imaging 2013; 29: 1043-50.